NCT04698629View on ClinicalTrials.gov

Hepatitis C Pharmacy-based Strategy for Injectors

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Hepatitis C
Trial Locations (1)

98104

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Washington

OTHER

NCT04698629 - Hepatitis C Pharmacy-based Strategy for Injectors | Biotech Hunter | Biotech Hunter